Putting Patients First: Patient-Centered Evidence & PROs in Biopharma
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Putting Patients First: Patient-Centered Evidence & PROs in Biopharma
-
Narrated by:
-
By:
Summary
This episode is part one of a three-part series featured on Fierce Pharma’s The Top Line podcast.
What does it really mean to put patients first in biopharma?
In this episode of Pharma Unscripted, we explore how patient-centered evidence, including patient-reported outcomes (PROs), is reshaping clinical development, regulatory expectations, and market access.
As decision-makers look beyond traditional endpoints, understanding the real patient experience, quality of life, treatment burden, and daily impact, is becoming essential.
Key Topics:
- Patient-reported outcomes (PROs)
- Patient-centered evidence generation
- Clinical trial design and endpoints
- Market access and patient experience
Guests:
- Ash Menon, Sr. Medical Affairs Lead
- Mark Price, Head of Expert Perspectives
adbl_web_anon_alc_button_suppression_c
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.